The main treatments for moderate to severe plaque psoriasis are biologics, such as anti‐interleukin (IL‐17), anti‐interleukin (IL‐23), and antitumor necrosis factor (TNF‐α), as well as oral agents.9, 10, 11. Here, TNF is linked to psoriasis vulgaris.